MCTS1 Antikörper (N-Term)
Kurzübersicht für MCTS1 Antikörper (N-Term) (ABIN453186)
Target
Alle MCTS1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- This antibody reacts to MCTS1.
-
Aufreinigung
- Saturated Ammonium Sulfate (SAS) precipitation
-
Immunogen
- KLH conjugated synthetic peptide selected from the N-terminal region of human MCTS1
-
-
-
-
Applikationshinweise
-
ELISA: 1/1,000. Western blotting: 1/50 - 1/100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- MCTS1 (Malignant T Cell Amplified Sequence 1 (MCTS1))
-
Andere Bezeichnung
- MCTS1
-
Hintergrund
- MCTS1 play a role in cell cycle regulation, decreases cell doubling time and anchorage-dependent growth, shortens the duration of G1 transit time and G1/S transition.Synonyms: MCT-1, MCT1, MCTS1, Malignant T cell amplified sequence 1
-
Gen-ID
- 28985
-
NCBI Accession
- NP_054779
-
UniProt
- Q9ULC4
Target
-